|Bid||81.91 x 100|
|Ask||121.16 x 300|
|Day's Range||116.12 - 121.45|
|52 Week Range||81.12 - 121.75|
|PE Ratio (TTM)||38.68|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q2 2017 Edwards Lifesciences Corp Earnings Call
Boston Scientific Corp on Thursday reported better-than-expected quarterly profit and revenue as the U.S. medical device maker benefited from strong demand across its businesses, which also helped the ...
Varian Medical's (VAR) solid performance in the Particle Therapy business and the launch of Halcyon radiotherapy treatment system were the key highlights of the third quarter.